DAFTAR PUSTAKA

1. Koff SR. Acute Liver Failure, In : Keeffe Eb, Friedman, LS.Handbook of liver
disease 2ed. Philadephia. 2008;30 34.
2. Thomas H, Lemon S, Zuckerman A (Eds). Viral Hepatitis. 3rd ed, Maiden:
Blacwell Publishing Ltd. 2007;81-84.
3. Sherlock S, Dooley J. Disease of the Liver and Billiary System.11th Ed.
Oxford: Blackwell Science Ltd. 2006;1-5.
4. Ruan Peng, Xu SY, Zhou BP, Huang J and Gong ZJ. Hepatitis B surface
antigen seroclearance inpatients with chronic hepatitis B infection : A clinical
study. Journal of International Medical research. 2013.
5. Ali Sulaiman. Hepatitis Virus. Buku Ajar Penyakit Hati. Edisi I. Jakarta :
FKUI, 2007;161 177.
6. Regev A, Schiff E. Clinical Features of Hepatitis In : Viral Hepatitis.
Blackwell pub. 2005;33 51.
7. Ozaras R, Tabrak F, Tahan V. Correlation of quanititative assay if HBsAg and
HBV DNA levels during chronic HBV treatment. Dig Dis Sci 2008;53(11):
2995-8.
8. Kukka C.M. HBV : How to interpret Hepatitis B antibody and Viral Test.
HCSP. Version2.0. 2008.
9. Bonino F, Piratvisuth T, Brunetto MR, Liaw YF. Diagnostic marker of chronic
hepatitis B infection and disease, antiviral therapy. Hepatology Research.
2010;35 44.
10. Tankijvanich P, Komolmit P, Mahacai V. Comparison between quantitative
hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA
levels for predicting virological response to pegylated interferon a-2b therapy
in hepatitis B e-antigen positive chronic hepatitis B. Hepatology Research.
2010;40: 269-277.
11. World Health Organization. Hepatitis Fact Sheet No. 204:2012. Available
from http://www.who.int/mediacentre/factsheets/fs204/en.

28
12. Mulyanto, Sulaiman, Depamede N, Surayah K, Tsuda F, Ichiyama K, et al. A
nationwide molecular epidemiological study on hepatitis virus in Indonesia:
identification of two novel subgenotypes, B8 and C7. Arch Virol 2009.
13. Gani RA. Masalah hepatitis di Indonesia. Dibawakan pada presentasi World
Hepatitis Day. 2012.
14. Haris KR and Dighe AS. Laboratory testing for viral hepatitis. Am J Clin an J
Pathol.2006; 118 (suppl) : S18-S25.
15. Dienstag J.L. Acut viral hepatits in.disorders of the liver and biliary tree.
Longo Gastroenterology. 2008 ; 349-377.
16. Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in
hepatitis B vaccinated children in Taiwan. 2008 European Association for the
study of the liver, Elsevier Inc. 2009 ; 50 (2): 264-72.
17. Weber B, Melchior W, Gehrke R, Doerr HV, Berger A, Rabenau H. Hepatitis
B virus markers in anti-HBc only positive individuals. J Med Virol 2006;
64:312-9.
18. Galli C, Orlandini E, Penzo L, Badiale R, Clatran G, Valverde S, Gessoni G.
What is the role of serology for the study of chronic hepatitis B virus
infection in the age of molecular biology? J. Med. Virol. 2008;80:974-9.
19. Ganem D and Alfred M. Prince. Hepatitis B Virus Infection-Natural History
and Clinical Consequences. N Engl Med. 2006;350:1118-29.
20. Yun Fan L, Leung N, Jia Horng K et al. Asian Pasific consensus statement on
the management of chronic hepatitis B:2 2008 up date. Hepatol mt
2008;2:263-283.
21. Hu Z, Li M, Huang B,Liu J .Detection of Hepatitis B virus preS1 antigen
using a time resolved fluorimmunoassay immunoassay immunochem
2012;33(2) :156- 165.
22. Yim H.J and Anna Suk-Fong. Natural History of Chronic Hepatitis B Virus
Infection: What We Knew in 1981 and What We Know in 2005. Hepatology
2006;43:S173-S181.
23. Thomas HC. Best practice in the treatment of chronic hepatitis B: A summary
of the European Viral Hepatitis Educational Initiative. J Hepatology 2007;
47:558-97.
24. Torbenson M, Thomas DL. Occult Hepatitis B. Lancet Infect Dis 2006; 2:
479-86.

29
25. Perhimpunan peneliti hati Indonesia (PPHI). Konsensus Nasional
Penatalaksanaan Hepatitis B di Indonesia. 2012 ;6-7.
26. Wu F, Wu MJ, Zhuge XL, Zhu SM, Zhu B. Correlation of the occurrence of
YMDD mutations with HBV genotypes, HBV DNA levels, and HBeAg status
in Chinese patients with chronic hepatitis B during lamivudine treatment.
Hepatobiliary Pancreat Dis Int. 2012;11(2):172-6.
27. Pawlotsky J-M. Use and Interpretation of Virological Tests for Hepatitis C.
Hepatology. 2005;36: S65-S73.
28. Rasenack. Serology of Viral hepatitis. In : Viral hepatitis diagnostics. Falk
foundation. 2009;7-20.
29. Kuo YH, Chang KC, Wang YH, Tsai PS et al . Is HCV core antigen (HCVAg)
an adequate marker for community screening. J.Clin Microbiol 2012;
abstract.
30. Djumhada A. Hepatitis non A, non B, non C. Buku ajar penyakit hati. Edisi I.
Jakarta : FKUI, 2007. H. 161 177.
31. Jeon MJ, shin JH, Suh SP, Lim YC, Ryang DW. TT virus and hepatitis G virus
infections in korean blood donors and patients with chronic liver disease.
World J gastroenterol 2007;9(4):741-744.
32. Asim M, singla R, Gupta RK & Kar P. Clinical & molecular
characterization of human TT virus in different liver disease. Indian J Med
Res 131, April 2010;545-554.

30